Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 9/20 | 0.60 |
| ▸ | MME | P08473 | 5/20 | 0.59 |
| ▸ | GNPAT | O15228 | 1/20 | 0.59 |
| ▸ | CPA1 | P15085 | 2/20 | 0.55 |
| ▸ | CPA2 | P48052 | 1/20 | 0.55 |
| ▸ | CPA4 | Q9UI42 | 1/20 | 0.55 |
| ▸ | CTSS | P25774 | 1/20 | 0.53 |
| ▸ | CTSK | P43235 | 1/20 | 0.53 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.53 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15692299 | 0.94 | MME (0.66) | ACEMMEGNPATCPA1CPA2 | |
| SCHEMBL15692300 | 0.94 | MME (0.66) | ACEMMEGNPATCPA1CPA2 | |
| SCHEMBL5997104 | 0.94 | MME (0.66) | ACEMMEGNPATCPA1CPA2 | |
| SCHEMBL7437335 | 0.92 | GNPAT (0.63) | ACEMMEGNPATCPA1CTSS | |
| SCHEMBL25627344 | 0.91 | BACE1 (0.55) | ACEGNPAT | |
| SCHEMBL30799905 | 0.90 | GNPAT (0.67) | ACEMMEGNPATCPA1CTSS | |
| SCHEMBL17732678 | 0.90 | GNPAT (0.67) | ACEMMEGNPATCPA1CTSS | |
| SCHEMBL30533197 | 0.90 | GNPAT (0.67) | ACEMMEGNPATCPA1CTSS | |
| SCHEMBL8903262 | 0.90 | ACE (0.61) | ACEMMEGNPATCPA1CPA2 | |
| SCHEMBL25627310 | 0.89 | MME (0.60) | ACEMMECPA1ACE2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023106897-A1 | NOVEL PEPTIDE DERIVATIVE DERIVED FROM ADIPONECTIN AND USE THEREOF | 서울대학교병원 | 2023-06-15 | — | — | WO | disclosed |